Shaonan Xie Qingyi Liu
10.3389/fonc.2022.977065
Front Oncol
2022 Sep 29;12:977065.
met amplification t790 m mutation epidermal growth factor receptor-tyrosine kinase inhibitors (egfr-tkis) resistance mechanism synchronous multiple primary lung cancer (smplc)
CC BY
https://pubmed.ncbi.nlm.nih.gov/36249035/
Case Reports
PMC9557219
36249035
Case report: Different mechanisms of drug resistance in a synchronous multiple primary lung cancer patient after EGFR-TKI treatment
2022